Prevalence of Charcot-Marie-Tooth disease across the lifespan: a population-based epidemiological study.

ABSTRACT:

Objectives

This population-based study aimed to determine age-standardised prevalence of Charcot-Marie-Tooth disease (CMT) across the lifespan using multiple case ascertainment sources.

Design

Point-prevalence epidemiological study in the Auckland Region of New Zealand (NZ).

Setting

Multiple case ascertainment sources including primary care centres, hospital services, neuromuscular disease registry, community-based organisations and self-referral were used to identify potentially eligible participants.

Participants

Adults (≥16 years, n=207, 87.7%) and children (<16 years, n=29, 12.3%) with a confirmed clinical or molecular diagnosis of CMT, hereditary sensory neuropathy, hereditary motor neuropathy or hereditary neuropathy with liability to pressure palsies who

SUBMITTER: Theadom A 

PROVIDER: S-EPMC6585838 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature